In CRC, the expression of YKL-40 was reported to be significantly correlated with that of PD-L1 in immune cells; in tumor cells, the expression of YKL-40 did not correlate with the expression of PD-L1 [1]. This evidence concerns the gene CHI3L1 and neoplasm.